Puts Sold on Keryx Biopharma (KERX)

Shares of Keryx Biopharmaceuticals KERX are higher on the session by 3.43%, currently trading at $3.62. The stock has been trading largely lower over the past three months, off from its highs near $6.70, which were reached during the ASCO conference. Options traders are selling puts on the name today. The August $2.50 put was sold 3,000 times, on the bid, for $0.10; open interest on the strike was only 10 contracts. The September $2.50 put was also sold, 2,000 times on the bid, for $0.20. Put volume is now running at 18.5x the daily average. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Long IdeasTechnicalsOptionsTrading IdeasAmerican Society of Clinical Oncology (ASCO)BiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!